Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia. (2022)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(21)00557-0

PubMed Identifier: 34919831

Publication URI: http://europepmc.org/abstract/MED/34919831

Type: Journal Article/Review

Volume: 22

Parent Publication: The Lancet. Infectious diseases

Issue: 4

ISSN: 1473-3099